Hints and tips:
...There was a March release date given for Gran Turismo 7 and the unfortunate slippage of Grand Theft Auto V from November to March. Axios has more....
...Lentz joins from Thompson & Knight. Latham & Watkins has hired Meghan Cocci as a partner in the law firm’s corporate department....
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...Directed by Zack Synder, 2016 Warner Bros The themes come thick and fast — the morality of power, democracy — but Batman v Superman skids across the surface, leaving characters and notions underdeveloped...
...At this year’s healthcare conference, he says, all the chatter is that Actavis “is actually going to be bigger than GlaxoSmithKline — now that really puts things in perspective”....
...The chief executive of GlaxoSmithKline all but ruled out a white knight bid by the UK pharmaceuticals company for AstraZeneca on Wednesday by reiterating scepticism on big takeover deals in the sector....
...Sanofi is among those touted by analysts as a potential “white knight,” but Chris Viehbacher, chief executive, this week said he was not looking to do a big deal....
...GlaxoSmithKline on Wednesday indicated it would not be tempted to mount a “white knight” bid to combine the UK’s two biggest drugmakers....
...Top shareholdings: Coca-Cola; ConocoPhillips; DirecTV; GlaxoSmithKline; General Electric; IBM. Portfolio Value: Berkshire’s equity portfolio was valued at $103.3bn at the end of June....
...Sir Andrew Witty, chief executive of GlaxoSmithKline, called for sustained co-ordinated efforts and more consistent tougher penalties around the world....
...GlaxoSmithKline is to acquire Human Genome Sciences for $3bn, bringing to an end a three-month hostile battle for control of the US biotech group best known for its pioneering drug for lupus....
...GlaxoSmithKline finalized its hostile takeover of Human Genome Sciences....
...Potential white knights knew they would have to partner with GSK.”...
...An investor has sued Human Genome Sciences in an effort to remove a “poison pill” unveiled by the US biotech company to help fend off GlaxoSmithKline’s $2.6bn hostile bid....
...Roche, GlaxoSmithKline, Eli Lilly and Bayer, all mentioned in media reports as potential white knights, have refused to discuss the matter....
...Kesa Electricals lost 0.5 per cent to 167½p after Knight Vinke, the activist investor, raised its stake in the retailer to 7 per cent....
...News of the lay offs, which was first reported on Wall Street Journal’s website, comes on the heels of lay offs by other big pharmaceutical companies including AstraZeneca and GlaxoSmithKline....
...It follows the UK example of British Gas, GlaxoSmithKline and Tomkins....
...The answer lay within “GlaxoSmithKline Appoints Witty CEO Designate.”...
...To the west, France has a national champion in Sanofi Aventis, while the UK has GlaxoSmithKline and AstraZeneca....
...In Feist Publications v Rural Telephone Service Company, Inc (1991), the US Supreme Court ruled that facts cannot be copyrighted....
...The two steelmakers in the battle for Canada’s Dofasco both advanced after Paris-listed Arcelor saw off the German white knight Thyssen Krupp....
...Novar, which Melrose values at 172½p a share, was reported to be looking round for a ‘white knight’ to defend it from Melrose....
International Edition